JP2014520854A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520854A5 JP2014520854A5 JP2014520312A JP2014520312A JP2014520854A5 JP 2014520854 A5 JP2014520854 A5 JP 2014520854A5 JP 2014520312 A JP2014520312 A JP 2014520312A JP 2014520312 A JP2014520312 A JP 2014520312A JP 2014520854 A5 JP2014520854 A5 JP 2014520854A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- hmf
- disease
- composition according
- composition comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 claims 22
- QVYAWBLDJPTXHS-UHFFFAOYSA-N 5-Hydroxymethyl-2-furfural Natural products OC1=CC=C(C=O)O1 QVYAWBLDJPTXHS-UHFFFAOYSA-N 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 9
- 206010021143 Hypoxia Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 230000007954 hypoxia Effects 0.000 claims 4
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 208000023504 respiratory system disease Diseases 0.000 claims 2
- 206010002388 Angina unstable Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 206010003497 Asphyxia Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010008088 Cerebral artery embolism Diseases 0.000 claims 1
- 206010051055 Deep vein thrombosis Diseases 0.000 claims 1
- 206010013647 Drowning Diseases 0.000 claims 1
- 208000003870 Drug Overdose Diseases 0.000 claims 1
- 208000000059 Dyspnea Diseases 0.000 claims 1
- 206010013975 Dyspnoeas Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
- 206010024119 Left ventricular failure Diseases 0.000 claims 1
- 208000032376 Lung infection Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000026072 Motor neurone disease Diseases 0.000 claims 1
- 208000034486 Multi-organ failure Diseases 0.000 claims 1
- 208000010718 Multiple Organ Failure Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010033296 Overdoses Diseases 0.000 claims 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 claims 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 208000010378 Pulmonary Embolism Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 206010039163 Right ventricular failure Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 206010047249 Venous thrombosis Diseases 0.000 claims 1
- 208000008445 altitude sickness Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000009267 bronchiectasis Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 231100000725 drug overdose Toxicity 0.000 claims 1
- 208000018578 heart valve disease Diseases 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims 1
- 201000010849 intracranial embolism Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000005264 motor neuron disease Diseases 0.000 claims 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 208000002815 pulmonary hypertension Diseases 0.000 claims 1
- 208000013220 shortness of breath Diseases 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161508260P | 2011-07-15 | 2011-07-15 | |
| US61/508,260 | 2011-07-15 | ||
| PCT/US2012/046427 WO2013012670A1 (en) | 2011-07-15 | 2012-07-12 | Treatment for hypoxia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014520854A JP2014520854A (ja) | 2014-08-25 |
| JP2014520854A5 true JP2014520854A5 (https=) | 2016-03-10 |
Family
ID=46551919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520312A Pending JP2014520854A (ja) | 2011-07-15 | 2012-07-12 | 低酸素症のための処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9918958B2 (https=) |
| EP (1) | EP2731602A1 (https=) |
| JP (1) | JP2014520854A (https=) |
| AU (1) | AU2012284361B2 (https=) |
| BR (1) | BR112014000889A2 (https=) |
| CA (1) | CA2841954C (https=) |
| WO (1) | WO2013012670A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016043849A2 (en) | 2014-07-24 | 2016-03-24 | Global Blood Therapeutics, Inc. | Compounds for treating acute respiratory distress syndrome or a negative effect thereof |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| JP7265237B2 (ja) * | 2017-07-27 | 2023-04-26 | 共栄化学工業株式会社 | 毛髪用組成物及び皮膚外用組成物 |
| WO2023061554A1 (en) * | 2021-10-11 | 2023-04-20 | Mitocai Ltd. | 5-hydroxymethylfurfural for the treatment of mitochondrial dysfunction |
| US11458144B1 (en) | 2021-12-23 | 2022-10-04 | King Abdulaziz University | Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sickling |
| CN117085005A (zh) * | 2023-10-08 | 2023-11-21 | 山东省科学院生物研究所 | 5-羟甲基-2-呋喃甲酸在制备促血管生成相关产品中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2507545C (en) | 2002-12-04 | 2011-06-21 | Virginia Commonwealth University | Use of furfural derivatives as anti-sickling agents |
| EP2255623A1 (en) * | 2009-05-26 | 2010-12-01 | Volker Wagner-Solbach | Plant nutriments |
| WO2011146471A1 (en) * | 2010-05-18 | 2011-11-24 | Aesrx Llc | Treatment for altitudinal hypoxia |
-
2012
- 2012-07-12 JP JP2014520312A patent/JP2014520854A/ja active Pending
- 2012-07-12 AU AU2012284361A patent/AU2012284361B2/en not_active Ceased
- 2012-07-12 US US13/547,462 patent/US9918958B2/en not_active Expired - Fee Related
- 2012-07-12 CA CA2841954A patent/CA2841954C/en not_active Expired - Fee Related
- 2012-07-12 BR BR112014000889A patent/BR112014000889A2/pt not_active Application Discontinuation
- 2012-07-12 WO PCT/US2012/046427 patent/WO2013012670A1/en not_active Ceased
- 2012-07-12 EP EP12738335.4A patent/EP2731602A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Naughton | Cheyne–Stokes respiration: friend or foe? | |
| JP2014520854A5 (https=) | ||
| Kohli et al. | Obstructive sleep apnea and the risk for cardiovascular disease | |
| JP2018530592A5 (https=) | ||
| JP2010522212A5 (https=) | ||
| JP2011144201A5 (https=) | ||
| JP2016500111A5 (https=) | ||
| JP2016510326A5 (https=) | ||
| JP2014533701A5 (https=) | ||
| Yang et al. | Advances in development of antiviral strategies against respiratory syncytial virus | |
| Gupta et al. | Inhaled Prostacyclin and High-Frequency Oscillatory Ventilation in a Premature Infant With Respiratory Syncytial Virus–Associated Respiratory Failure | |
| JP2015521157A5 (https=) | ||
| JP2015512439A5 (https=) | ||
| Kogan et al. | B67 DIAGNOSIS, TREATMENT, AND MANAGEMENT OF SLEEP DISORDERED BREATHING: Respiratory Inductance Plethysmography Improves Diagnostic Sensitivity And Specificity Of Obstructive Sleep Apnea | |
| JP2019505538A5 (https=) | ||
| RU2015131803A (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
| Zhuang | Advances in mechanical ventilation onrespiratoryfailure as a result of chronic obstructive pulmonary disease and bronchial asthma | |
| JP2017524732A5 (https=) | ||
| RU2600822C1 (ru) | Способ лечения хронического обструктивного бронхита | |
| Rodenstein et al. | Respiratory Failure In Restrictive Disorders: Effects Of Non Invasive Ventilation On Sleep Characteristics | |
| Oldenburg et al. | Cycle Lengths Of Obstructive Sleep Apnea Parameters Are Dependent On Left Ventricular Filling And Pulmonary Artery Pressures In Patients With Systolic Heart Failure | |
| Murase et al. | Evaluation and Comparison of the Effect of Two Chinese Herbal Medicines (Bofu-tsusho-san and Dai-saiko-to) on Metabolic Disorders in Obstructive Sleep Apnea Patients | |
| Singh et al. | A rare cause of hypoxia in a patient with liver cirrhosis | |
| Deleanu et al. | Importance Of Proper Cpap Therapy For A Long Period Of Time In Terms Of Cardiovascular Risk Evaluated By Pulse Pressure In Obstructive Sleep Apnea Patients Associating Resistant Hypertension | |
| Lee et al. | D35 RARE AND INTERESTING CASES OF LUNG INFLAMMATION, INJURY, AND INFECTION: Recurrent Lobar Atelectasis In An Adult Asthmatic Patient: The Importance Of Collateral Ventilation |